What is the Cardiovascular and Metabolic Research Network?
Our multidisciplinary research network interdigitates scientists and clinicians from UEA Faculty of Science, Faculty of Medicine & Health, and the Norfolk & Norwich University Hospital.
We work together to understand and tackle cardiovascular and metabolic disease, including heart disease, diabetes, stroke and vascular dementia. Major funders within the network include BBSRC, British Heart Foundation, NIHR Wellcome Trust and industrial partners.
Thematic research areas
-
Vascular and stroke
-
Stem cell and regenerative medicine
-
Diabetes and metabolism
-
Cardiac
Our mission
-
Understand the rules of life of cells and tissues in the cardiovascular and metabolic cells and tissues
-
Develop better therapies, diagnosis and clinical practice in cardiovascular and metabolic disease
-
Develop new talent through postgraduate research, research fellowships and an excellent training environment
"Multidisciplinary working is essential for us to understand the complex physiology of our cardiovascular system, what goes wrong in disease, and how to predict, diagnose and treat disease. We are uniquely placed in close proximity on the Norwich Research Park to deliver this.”
Professor Sam Fountain
Network Director and Chair of Pharmacology
Fellowships and collaboration
The network is open to hosting UKRI and British Heart Foundation Basic and Clinical Fellowships. Contact Professor Sam Fountain to discuss how we can best support your application.
2024/2025 Seminar Series
Talk title: TBC
Professor Nicola Smart, University of Oxford
Date and Time: Thursday 17 October, 1-2pm
Venue: TBC
Host: Dr Linda Troeberg, UEA MED
Speaker bio: TBC
Hear from some of our researchers
Research Overview
Helen’s interest is in early-onset T2D (T2D before 39 years of age) which is associated with hypertension, hyperlipidemia and a severe cardio-metabolic phenotype. Helen hopes that her research will help those with early-onset T2D.
“Those with early-onset T2D are predominantly female, poor and from minority racial/ethnic groups. Females are disproportionately affected by early-onset T2D and this has major implications for reproductive health and future pregnancies.”